Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five-Year Outcomes for Patients With RVOT Dysfunction Treated With the SAPIEN 3 Transcatheter Heart Valve: A Pooled Analysis From the COMPASSION S3 Trial.

Circulation. Cardiovascular interventions·2026
Same author

Environment-sensitive motion modelling in healthcare with synthetic retargeting.

Digital health·2026
Same author

Overall side-effect bother consistently associated with early treatment discontinuation due to adverse events in four clinical trials with various cancer types and treatments.

Cancer·2025
Same author

Wildfire management at a crossroads: Mitigation and prevention or response and recovery?

Science (New York, N.Y.)·2025
Same author

Ipatasertib in Patients with Tumors with AKT Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1K.

Clinical cancer research : an official journal of the American Association for Cancer Research·2025
Same author

A case of <i>Flavobacterium lindani</i> <i>tolerans</i> meningitis and bacteraemia in an immunocompetent host.

New microbes and new infections·2025
Same journal

Outcomes of conduction system and right ventricular pacing in bradyarrhythmia indications: A systematic review and meta-analysis of propensity-score matched and randomized studies.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same journal

Single-shot ablation for AF: Real-world procedural and one-year outcomes with the newly adopted PulseSelect PFA compared with cryoballoon from the 1STOP project.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same journal

Sex differences in escalation to atrioventricular node ablation following catheter ablation for atrial fibrillation.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same journal

Focal pulsed field ablation for complex ventricular arrhythmias after prior failed or intraprocedurally ineffective radiofrequency ablation.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same journal

Machine learning prediction of mechanical dilatation in transvenous lead extraction for cardiac device-related infections: insights from a high-volume centre.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same journal

Heterogeneity in endpoints, monitoring methods and blanking periods in clinical trials of atrial fibrillation ablation: a systematic review and meta-analysis.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

Pacemaker implantation in the extreme elderly.

Robert T Stevenson1, David Lugg, Robert Gray

  • 1Heart Rhythm Center, Lebanon Cardiology Associates, Lebanon, PA 17042, USA.

Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing
|September 28, 2011
PubMed
Summary
This summary is machine-generated.

Pacemaker implantation in patients aged 80 and older showed low complication rates comparable to younger groups. However, 30-day all-cause mortality was higher, reflecting general risks in this extreme elderly population.

More Related Videos

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Related Experiment Videos

Last Updated: May 29, 2026

Translational Rabbit Model of Chronic Cardiac Pacing
06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation
08:56

Sterile Pericarditis in Aachener Minipigs As a Model for Atrial Myopathy and Atrial Fibrillation

Published on: September 24, 2021

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Area of Science:

  • Cardiology
  • Geriatric Medicine
  • Medical Device Technology

Background:

  • Limited data exists on pacemaker implantation complications and readmission rates in the extreme elderly (≥80 years).
  • Pacemaker use is common in this demographic, necessitating further investigation into associated risks.

Purpose of the Study:

  • To evaluate the safety and efficacy of pacemaker implantation in patients aged 80 years and older.
  • To determine complication and readmission rates within 30 days of pacemaker implantation in this population.

Main Methods:

  • Retrospective chart review of 149 patients (≥80 years) undergoing pacemaker implantation.
  • Analysis included single-, dual-, and biventricular pacemakers and generator changes.
  • Major and minor complications were defined, and 30-day outcomes were assessed.

Main Results:

  • Mean age of implantation was 86 years; no intraprocedural complications occurred.
  • Overall 30-day complication rate was 5.4% (2.7% major, 2.7% minor).
  • 30-day readmission rate was 5.4%, with 0.7% cardiovascular-attributable mortality and 2% all-cause mortality.

Conclusions:

  • Pacemaker implantation in the extreme elderly demonstrates complication rates comparable to younger populations.
  • Higher 30-day all-cause mortality in this group may be linked to inherent risks associated with advanced age.